MySebDermTeam

Is Zoryve (roflumilast) effective for seborrheic dermatitis? The short answer is: yes, the clinical trial results look pretty promising!

Zoryve foam was FDA-approved in December 2023 for people aged 9 and older. It's a once-daily, steroid-free foam that works by reducing inflammation through a mechanism called PDE4 Show Full Answer

Is Zoryve (roflumilast) effective for seborrheic dermatitis? The short answer is: yes, the clinical trial results look pretty promising!

Zoryve foam was FDA-approved in December 2023 for people aged 9 and older. It's a once-daily, steroid-free foam that works by reducing inflammation through a mechanism called PDE4 inhibition — basically, it helps calm the immune response that triggers seborrheic dermatitis symptoms. Here's what the clinical trial (called the Stratum phase 3 study) found after 8 weeks of use:

- 80% of users achieved clear or almost clear skin
- 50% experienced complete clearance of skin symptoms
- 60%+ had a significant reduction in itch severity
- 28% felt improvement within just 2 days
- Some participants saw noticeable improvement as early as week two

The treatment was also reported to be safe and well tolerated.

It's worth having a conversation with your dermatologist to see if Zoryve could be a good fit for your specific situation, as everyone's skin responds differently.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

FDA Approves Zoryve Foam To Treat Seborrheic Dermatitis